Translational molecular imaging in exocrine pancreatic cancer - Université d'Angers Accéder directement au contenu
Article Dans Une Revue European Journal of Nuclear Medicine and Molecular Imaging Année : 2018

Translational molecular imaging in exocrine pancreatic cancer

Résumé

Effective treatment for pancreatic cancer remains challenging, particularly the treatment of pancreatic ductal adenocarcinoma (PDAC), which makes up more than 95% of all pancreatic cancers. Late diagnosis and failure of chemotherapy and radiotherapy are all too common, and many patients die soon after diagnosis. Here, we make the case for the increased use of molecular imaging in PDAC preclinical research and in patient management.

Domaines

Cancer
Fichier principal
Vignette du fichier
PubliLatifaEq132018.pdf (10.38 Mo) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

inserm-01885212 , version 1 (01-10-2018)

Identifiants

Citer

Bart Cornelissen, James Knight, Somnath Mukherjee, Laura Evangelista, Catarina Xavier, et al.. Translational molecular imaging in exocrine pancreatic cancer. European Journal of Nuclear Medicine and Molecular Imaging, 2018, Epub ahead of print. ⟨10.1007/s00259-018-4146-5⟩. ⟨inserm-01885212⟩
52 Consultations
115 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More